Next Article in Journal
Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients
Next Article in Special Issue
A Review of Trastuzumab Biosimilars in Early Breast Cancer and Real World Outcomes of Neoadjuvant MYL-1401O versus Reference Trastuzumab
Previous Article in Journal
Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V2) Therapy
 
 
Review

Article Versions Notes

Curr. Oncol. 2022, 29(6), 4125-4137; https://doi.org/10.3390/curroncol29060329
Action Date Notes Link
article xml file uploaded 6 June 2022 14:16 CEST Original file -
article xml uploaded. 6 June 2022 14:16 CEST Update https://www.mdpi.com/1718-7729/29/6/329/xml
article pdf uploaded. 6 June 2022 14:17 CEST Version of Record https://www.mdpi.com/1718-7729/29/6/329/pdf
article html file updated 6 June 2022 14:18 CEST Original file -
article html file updated 3 August 2022 03:45 CEST Update https://www.mdpi.com/1718-7729/29/6/329/html
Back to TopTop